European Archives - Page 751 of 1168 - European Medical Journal

Obstructive Sleep Apnea and Objective Sleep Quality in Non-Dialysed Patients with Chronic Kidney Disease: An European Sleep Apnea Database (ESADA) Study

Short sleep duration and poor sleep quality have been reported in chronic kidney disease (CKD). Additionally, sleep disordered breathing (SDB)…

Changes in Biomarkers in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib and Sildenafil

Nintedanib is a tyrosine kinase inhibitor approved for the treatment of idiopathic pulmonary fibrosis (IPF). Sildenafil is a phosphodiesterase-5…

A Respiratory Review of Australian Men with Coal Mine Dust Lung Disease

In Queensland, Australia, coal mining is a large industry in terms of both employment and economy…

Asthma in Children Under 5 Years in Rural Kyrgyzstan: A Diagnostic Vacuum? a Qualitative FRESH AIR Study

Worldwide, asthma is the most frequent non-communicable disease in childhood, often starting in infancy.

Retrospective Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort

Latest guidelines in pulmonary arterial hypertension (PAH) recommend the use of multi-parameter risk assessment at both diagnosis…

EMJ Respiratory 7.1 2019

Introducing all our readers this year’s edition of EMJ Respiratory, an eJournal fit to burst with the latest hotly discussed topics and research findings…

Talking to Eric Bouilloux

Eric Bouilloux, Chief of Staff, Global Medical Affairs, Ipsen, discusses his career path to his current position and also share his views on the evolution of medical affairs.

Intervention in Malaria Parasite Journey May Reduce Disease Transmission

THE JOURNEY taken by malaria Plasmodium parasites for invasion of the liver may now be detectable, according to a new study…

Delayed Onset of Alzheimer’s Initiated by Anticoagulant in Mice

DELAYED onset of Alzheimer’s disease caused by a well-known anticoagulant has been demonstrated in a mouse model…

Predicting Methotrexate Response in Rheumatoid Arthritis Patients

CHANGES in DNA methylation at 4 weeks of methotrexate treatment for rheumatoid arthritis (RA) were associated with improvements in symptoms at 6 months…